[Antiviral chemotherapeutic agents. XVII. Potential interferon inducers: adamantane derivatives].
D000818:Animals; D000998:Antiviral Agents / Q000008:administration & dosage / Q000138:chemical synthesis* / Q000494:pharmacology; D001952:Bridged-Ring Compounds / Q000138:chemical synthesis* / Q000494:pharmacology; D003516:Cycloparaffins / Q000138:chemical synthesis / Q000494:pharmacology; D004048:Diethylamines / Q000138:chemical synthesis / Q000494:pharmacology; D005449:Fluorenes / Q000138:chemical synthesis / Q000494:pharmacology; D007274:Injections, Intraperitoneal; D007369:Interferon Inducers / Q000008:administration & dosage / Q000138:chemical synthesis* / Q000494:pharmacology; D008574:Mengovirus / Q000187:drug effects; D051379:Mice
D000998:Antiviral Agents; D001952:Bridged-Ring Compounds; D003516:Cycloparaffins; D004048:Diethylamines; D005449:Fluorenes; D007369:Interferon Inducers
Chemioterapici antivirali. Nota XVII. Potenziali induttori di interferon: derivati adamantanici